The role of endocannabinoids in the regulation of luteinizing hormone and prolactin release. Differences between the effects of AEA and 2AG

Molecular and Cellular Endocrinology

Volumn 286, Issue 1-2 SUPPL. 1, 2008, Pages

  Oláh, Márk ^a   Milloh, Hadar ^a   Wenger, Tibor ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

CB1 KO mouse; Endocannabinoids; Luteinizing hormone; Prolactin

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ANANDAMIDE; CANNABINOID 1 RECEPTOR; CAPSAZEPINE; ENDOCANNABINOID; LUTEINIZING HORMONE; PROLACTIN; VANILLOID RECEPTOR 1;

ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; GENE EXPRESSION; HORMONE BLOOD LEVEL; HORMONE RELEASE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ARACHIDONIC ACIDS; ENDOCANNABINOIDS; GLYCERIDES; GONADOTROPHS; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; LUTEINIZING HORMONE; MALE; MICE; POLYUNSATURATED ALKAMIDES; PROLACTIN; RECEPTOR, CANNABINOID, CB1;

EID: 42249096291     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2008.01.005     Document Type: Article

References (28)

1. Chakravarty I., Sheth A.R., and Ghosh J.J. Effects of acute Δ9-tetrahydrocannabinol treatment of serum luteinizing hormone and prolactin levels in adult female rats. Fertil. Steril. 26 (1975) 947-948
2. Di Marzo V., DePetrocellis L., Fezza F., Ligresti A., and Bisogno T. Anandamide receptors. Prostaglandins Leukot. Essent. Fatty Acids 66 (2002) 377-391
3. Di Marzo V., De Petrocellis L., and Bisogno T. The biosynthesis, fate and pharmacological properties of endocannabinoids. In: Pertwee R.G. (Ed). Cannabinoids (2005), Springer-Verlag, Berlin, Heidelberg 147-186
4. Eljaschewitsch E., Witting A., Mawrin C., Lee T., Schmidt P.M., Wolf S., Hoertnagl H., Raine C.S., Schneider-Stock R., Nitsch R., and Ullrich O. The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells. Neuron 49 (2006) 67-79
5. 1 receptors in hypothalamic structures and their involvement in the effects of cannabimimetics. Biochem. Pharmacol. 53 (1997) 1919-1927
6. 1 receptor mRNA in the pituitary gland. Neuroendocrinology 70 (1999) 137-145
7. 1 receptor mRNA and endocannabinoid levels in the anterior pituitary gland. Biochem. Biophys. Res. Commun. 270 (2000) 260-266
8. Herkenham M. Localization of cannabinoid receptors in brain and periphery. In: Pertwee R.G. (Ed). Cannabinoid Receptors (1995), Academic Press, London, San Diego 145-166
9. 1 receptor knockout mice. Science 283 (1999) 401-404
10. Mechoulam R., and Hanus L. A historical overview of chemical research on cannabinoids. Chem. Phys. Lipids 108 (2000) 1-13
11. Maccarrone M., and Wenger T. Effects of cannabinoids on hypothalamic and reproductive function. In: Pertwee R.G. (Ed). Cannabinoids (2005), Springer-Verlag, Berlin, Heidelberg 555-572
12. Marks B.H. Δ9-Tetrahydrocannabinol and luteinizing hormone secretion. Prog. Brain Res. 39 (1973) 331-338
13. Mezey E., Toth Z.E., Corthright D.N., Arzubi M.K., Krause J.E., Elde R., Guo A., Blumberg P.M., and Szallasi A. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 3655-3660
14. 1 cannabinoid receptor in the rat brain. An immunohistochemical study. Peptides 21 (2000) 1735-1742
15. Murphy L. Cannabinoids and the neuroendocrine system. In: Wenger T. (Ed). Recent Advances in Pharmacology and Physiology of Cannabinoids (2004), Research Signpost, Trivandrum 217-236
16. Pertwee R.G. Pharmacological action of cannabinoids. In: Pertwee R.G. (Ed). Cannabinoids (2005), Springer-Verlag, Berlin, Heidelberg 1-52
17. Romero J., Wenger T., deMiguel R., Ramos J., and Fernández-Ruiz J.J. Cannabinoid receptor binding did not vary in several hypothalamic nuclei after deafferentation. Life Sci. 63 (1998) 351-356
18. Ross R.A. Anandamide and vanilloid TRPV1 receptors. Br. J. Pharmacol. 140 (2003) 790-801
19. Scorticati C., Mohn C., De Laurentiis A., Vissio P., Fernandez-Solari C., Seilicovich A., McCann S., and Rettori V. The effect of anandamide on prolactin secretion is modulated by estrogen. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 2134-2139
20. Sugiura T., Oka S., Gokoh M., and Waku K. Physiology roles of 2-arachidonoyl glycerol, an endogenous cannabinoid receptor ligand, in neuromodulation and inflammation. In: Wenger T. (Ed). Recent Advances in Pharmacology and Physiology of Cannabinoids (2004), Research Signpost, Trivandrum 97-118
21. Szallasi A., and Blumberg M. Vanilloid (capsaicin) receptors and mechanisms. Pharm. Rev. 51 (1999) 159-212
22. Tyrey C. Δ9-Tetrahydrocannabinol: a potent inhibitor of episodic luteinizing hormone secretion. J. Pharmacol. Exp. Ther. 213 (1980) 306-308
23. Wenger T., Rettori V., Snyder G., Dalteiro S., and McCann S. Effects of Δ9-tetrahydrocannabinol (THC) on the hypothalamic-pituitary control of LH and FSH secretion in adult male rats. Neuroendocrinology 46 (1987) 488-493
24. Wenger T., Croix D., Tramu G., and Leonardelli J. Effects of Δ9-tetrahydrocannabinol on pregnancy, puberty and the neuroendocrine system. In: Murphy L., and Bartke A. (Eds). Marijuana/Cannabinoids (1992), CRC Press, Boca Raton 539-560
25. 1 receptors in the anterior lobe of the pituitary gland. J. Neuroendocrinol. 11 (1999) 873-878
26. Wenger T., Jamali K.A., Juanéda C., Bácsy E., and Tramu G. The endogenous cannabinoid, anandamide regulates anterior pituitary secretion in vitro. Addict. Biol. 5 (2000) 59-64
27. Wenger T., Ledent C., Csernus V., and Gerendai I. The central cannabinoid receptor inactivation suppresses endocrine reproductive functions. Biochem. Biophys. Res. Commun. 284 (2001) 363-368
28. 1 cannabinoid receptor knockout mice. Neuroendocrinology 78 (2003) 294-300